Mozes 16
Food supplement declared in France, declaration No 2019-3-769, decision dated 18 March 2019
Mozes 16 (Titis) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food). 2 rules of use apply to its ingredients (limits and warnings).
- Brand
- Titis
- Food business operator placing the product on the market
- LABORATOIRES TBC TITIS
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 2 gélules
- Directions for use
- Prendre 2 gélules par jour (1 matin, 1 le soir)
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Enfants (moins de 12 ans), Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Immunité
Declaration 294301, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
Contains a preparation of rhubarb (Rheum palmatum) (rhizome). Preparations from this plant part containing hydroxyanthracene derivatives are under Union scrutiny (Annex III, Part C): a draft regulation sent to the Council on 15 July 2026 would prohibit them, with 12 months to sell through products already on the market. Their content is not declared.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie C (règlement (UE) 2021/468) ; projet de la Commission D099926/3.
- Conditions légales
Hyssopus officinalis L.: L'huile essentielle de cette plante est interdite.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Rheum palmatum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Berberis aristata DC. | Racine | Extrait sec aqueux | 200 mg |
| Olea europaea L. | Feuille | Extrait sec aqueux | 120 mg |
| Piper longum L. | Fruit | Extrait sec aqueux | 120 mg |
| Salvia officinalis L. | Parties aériennes | Extrait sec aqueux | 90 mg |
| Punica granatum L. | Fruit (écorce) | Extrait sec aqueux | 80 mg |
| Panax ginseng C.A.Mey. | Rhizome | Extrait sec aqueux | 70 mg |
| Hibiscus sabdariffa L. | Fleur | Extrait sec aqueux | 50 mg |
| Carica papaya L. | Feuille | Extrait sec aqueux | 40 mg |
| Illicium verum Hook.f. | Ecorce | Extrait sec aqueux | 40 mg |
| Melissa officinalis L. | Parties aériennes | Extrait sec aqueux | 40 mg |
| Mentha x piperita L. | Parties aériennes | Extrait sec aqueux | 40 mg |
| Hyssopus officinalis L. | Parties aériennes | Extrait sec aqueux | 30 mg |
| Rheum palmatum L. | Rhizome | Extrait sec aqueux | 20 mg |
| Rosmarinus officinalis L. | Parties aériennes | Extrait sec aqueux | 20 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Titis